Shock Syndromes II
Hypovolemic Shock
Alvarado R, Chung KK, Cancio LC, Wolf SE. Burn
resuscitation.
Burns.
2009;35(1):4-14. https://doi.
org/10.1016/j.burns.2008.03.008
American College of Surgeons. Committee on Trauma:
Advanced Trauma Life Support Manual. American
College of Surgeons; 1997:103-112.
Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et
al. Platelet transfusion versus standard care after acute
stroke due to spontaneous cerebral haemorrhage associ-
ated with antiplatelet therapy (PATCH): a randomised,
2613. https://doi.org/10.1016/s0140-6736(16)30392-0
Baksaas-Aasen K, Gall LS, Stensballe J, et al.
Viscoelastic haemostatic assay augmented protocols for
major trauma haemorrhage (ITACTIC): a randomized,
https://doi.org/10.1007/s00134-020-06266-1
Boffard KD, Riou B, Warren B, et al. Recombinant fac-
tor VIIa as adjunctive therapy for bleeding control in
severely injured trauma patients: two parallel random-
ized, placebo-controlled, double-blind clinical trials.
J Trauma. 2005;59(1):8-18. https://doi.org/10.1097/01.
ta.0000171453.37949.b7
Bourke DL, Smith TC. Estimating allowable hemodi-
lution. Anesthesiology. 1974;41(6):609-612. https://doi.
org/10.1097/00000542-197412000-00015
Bouzat P, Charbit J, Abback PS, et al. Efficacy and safety
of early administration of 4-factor prothrombin complex
concentrate in patients with trauma at risk of massive
transfusion: the PROCOAG randomized clinical trial.
jama.2023.4080
Brohi K, Singh J, Heron M, Coats T. Acute traumatic
coagulopathy. J Trauma. 2003;54(6):1127-1130. https://
doi.org/10.1097/01.ta.0000069184.82147.06
Cannon JW. Hemorrhagic shock. N Engl J Med.
2018;378(4):370-379.
https://doi.org/10.1056/
nejmra1705649
Cannon JW, Khan MA, Raja AS, et al. Damage control
resuscitation in patients with severe traumatic hemor-
rhage: a practice management guideline from the Eastern
Association for the Surgery of Trauma. J Trauma Acute
Care Surg. 2017;82(3):605-617. https://doi.org/10.1097/
ta.0000000000001333
Carney N, Totten AM, O’Reilly C, et al. Guidelines for
the management of severe traumatic brain injury, fourth
edition. Neurosurgery. 2017;80(1):6-15. https://doi.
org/10.1227/NEU.0000000000001432
Connolly SJ, Crowther M, Eikelboom JW, et al. Full study
report of andexanet alfa for bleeding associated with
factor Xa inhibitors. N Engl J Med. 2019;380(14):1326-
1335. https://doi.org/10.1056/nejmoa1814051
Connolly SJ, Sharma M, Cohen AT, et al. Andexanet for
factor Xa inhibitor-associated acute intracerebral hem-
orrhage. N Engl J Med. 2024;390(19):1745-1755. https://
doi.org/10.1056/nejmoa2313040
CRASH-2 Trial Collaborators; Shakur H, Roberts
I, Bautista R, et al. Effects of tranexamic acid on
death, vascular occlusive events, and blood transfu-
sion in trauma patients with significant haemorrhage
(CRASH-2): a randomised, placebo-controlled trial.
s0140-6736(10)60835-5
CRASH-3 Trial Collaborators. Effects of tranexamic
acid on death, disability, vascular occlusive events and
other morbidities in patients with acute traumatic brain
injury (CRASH-3): a randomised, placebo-controlled
org/10.1016/s0140-6736(19)32233-0
Dager WE. Developing a management plan for oral anti-
suppl 1):S21-S31. https://doi.org/10.2146/ajhp130042
De Backer D, Biston P, Devriendt J, et al. Comparison
of dopamine and norepinephrine in the treatment of
shock. N Engl J Med. 2010;362(9):779-789. https://doi.
org/10.1056/nejmoa0907118
Delano MJ, Rizoli SB, Rhind SG, et al. Prehospital resus-
citation of traumatic hemorrhagic shock with hypertonic
solutions worsens hypocoagulation and hyperfibrinoly-
sis. Shock. 2015;44(1):25-31. https://doi.org/10.1097/
shk.0000000000000368
Eriksson BI, Quinlan DJ, Weitz JI. Comparative phar-
macodynamics and pharmacokinetics of oral direct
thrombin and factor Xa inhibitors in development.
Clin
Pharmacokinet.
2009;48(1):1-22.
https://doi.
org/10.2165/0003088-200948010-00001